Just a moment...
We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic
• Quick overview summary answering your query with references
• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced
• Includes everything in Basic
• Detailed report covering:
- Overview Summary
- Governing Provisions [Acts, Notifications, Circulars]
- Relevant Case Laws
- Tariff / Classification / HSN
- Expert views from TaxTMI
- Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.
Help Us Improve - by giving the rating with each AI Result:
Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the products "TruSeq Stranded mRNA, Nextera DNA CD Idx and NextSeq 1000/2000 reagents" are classifiable under tariff item 3822 1990 of the First Schedule to the Customs Tariff Act, 1975.
Analysis: The products are prepared laboratory reagents presented in liquid state, put up in kits and labelled for research use only, intended for in vitro application. Under Rule 3(b) read with Rule 1 of the General Rules for the Interpretation of the First Schedule, a composite good is classified by the component that imparts its essential character; here the reagents are the essential component. Heading 3822 covers prepared diagnostic or laboratory reagents, whether or not put up in kits, excluding items of heading 3006 and certified reference materials as defined in Note 2(A) to Chapter 38. The products are not designed to be administered to patients nor are they certified reference materials; they are not pregnancy, malaria, Zika or blood-grouping kits and hence are not covered by the specifically enumerated subheadings. Applying Rule 6 and Rule 3(a) of the GRI, the most specific applicable provision is Sub Heading 3822 19 and, within it, the residual tariff item 3822 1990.
Conclusion: The products "TruSeq Stranded mRNA, Nextera DNA CD Idx and NextSeq 1000/2000 reagents" are classifiable under tariff item 3822 1990 of the First Schedule to the Customs Tariff Act, 1975.